FOLH1 and posterior cortical atrophy: In the neoadjuvant setting, Golan et al. assessed the safety and early outcome of 2–3 cycles of 7.4 GBq of [177Lu]Lu-PSMA-I&T at 2 weeks intervals before radical prostatectomy (RPE, 4 weeks after the last RLT) in 14 high-risk localized PCa with high PSMA uptake at [68Ga]Ga-PSMA-I&T PET/computed tomography (CT).